Form 144 IRULYA THERAPEUTICS INC For: 21 October
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IRulya Therapeutics Inc (IRLA)
IRulya Therapeutics Inc stock price live, this page displays NASDAQ IRLA stock exchange data. View the IRLA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IRulya Therapeutics Inc real time stock price chart below.
What Is the IRulya Therapeutics Inc Stock Price Today?
The IRulya Therapeutics Inc stock price today is 33,160.
What Is the Stock Symbol for IRulya Therapeutics Inc?
The stock symbol for IRulya Therapeutics Inc is "IRLA."
What Stock Exchange Does IRulya Therapeutics Inc Trade On?
IRulya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is IRulya Therapeutics Inc a Good Stock to Buy?
Determining whether IRulya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRLA quote. (ISIN: US22053A3059)
What Is the IRulya Therapeutics Inc Stock Price Today?
The IRulya Therapeutics Inc stock price today is 33,160.
What Is the Stock Symbol for IRulya Therapeutics Inc?
The stock symbol for IRulya Therapeutics Inc is "IRLA."
What Stock Exchange Does IRulya Therapeutics Inc Trade On?
IRulya Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is IRulya Therapeutics Inc a Good Stock to Buy?
Determining whether IRulya Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRLA quote. (ISIN: US22053A3059)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.850
33.545
52 wk Range
3.660
909.980
Earnings results expected in 15 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.85033.545
52 wk Range
3.660909.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IRLA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
75.000
Upside
+126.18%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 75.000
(+126.18% Upside)
Earnings
Latest Release
Aug 14, 2026
EPS / Forecast
-12,31 / -9,40
Revenue / Forecast
-- / --
Compare IRLA to Peers and Sector
Metrics to compare | IRLA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRLAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −1.7x | −0.2x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | −0.9x | 1.6x | 2.6x | |
Price / LTM Sales | - | 3.2x | 2.8x | |
Upside (Analyst Target) | 126.2% | 332.6% | 65.5% | |
Fair Value Upside | Unlock | 1.6% | 8.9% | Unlock |
IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company’s lead asset candidate comprises eDSP, which is in Phase 3 for the treatment of rare pediatric neurodegenerative diseases, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in the ATM gene. Its AIDE technology platform is a drug/device combination platform that uses an automated process to encapsulate a drug into a patient’s own red blood cells and consists of automated equipment, the RCL, a sterile single-use consumable treatment kit comprising medical device kits, syringe kits, and process solutions. IRulya Therapeutics Inc. was formerly known as Quince Therapeutics, Inc. and changed its name to IRulya Therapeutics Inc. in October 2026. The company was incorporated in 2012 and is headquartered in New Haven, Connecticut.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the IRulya (IRLA) Stock Price Today?
The IRulya stock price today is 33,160 USD.
What Stock Exchange Does IRulya Trade On?
IRulya is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for IRulya?
The stock symbol for IRulya is "IRLA."
What Is the IRulya Market Cap?
As of today, IRulya market cap is 34,120M USD.
What Is IRulya's Earnings Per Share (TTM)?
The IRulya EPS (TTM) is -51,81.
When Is the Next IRulya Earnings Date?
IRulya will release its next earnings report on Nov 18, 2026.
From a Technical Analysis Perspective, Is IRLA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has IRulya Stock Split?
IRulya has split 2 times.
How Many Employees Does IRulya Have?
IRulya has 38 employees.
What is the current trading status of IRulya (IRLA)?
As of Nov 03, 2026, IRulya (IRLA) is trading at a price of 33,160 USD, with a previous close of 33,550 USD. The stock has fluctuated within a day range of 31,850 USD to 33,545 USD, while its 52-week range spans from 3,660 USD to 909,980 USD.
What Is IRulya (IRLA) Price Target According to Analysts?
The average 12-month price target for IRulya is 75,000 USD, with a high estimate of 98 USD and a low estimate of 65 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126,18% Upside potential.
What Is the IRLA Premarket Price?
IRLA's last pre-market stock price is 32,800 USD. The pre-market share volume is 60,000, and the stock has decreased by -0,750, or -2,240%.
What Is the IRLA After Hours Price?
IRLA's last after hours stock price is 32,090 USD, the stock has decreased by -1,070, or -3,230%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.